We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EQHA
3676
DELISTED
EQ Health Acquisition Corp.
EQHA
-976,238
Closed -$9.65M
HCIC
3677
DELISTED
Hennessy Capital Investment Corp. V Class A Common Stock
HCIC
-1,589,995
Closed -$15.7M
HCICW
3678
CALL
DELISTED
Hennessy Capital Investment Corp. V Warrant
HCICW
-336,247
Closed -$3.32M
GNAC
3679
DELISTED
Group Nine Acquisition Corp. Class A Common stock
GNAC
-1,127,090
Closed -$11.1M
HCIIW
3680
CALL
DELISTED
Hudson Executive Investment Corp. II Warrant
HCIIW
-162,495
Closed -$1.62M
HCII
3681
DELISTED
Hudson Executive Investment Corp. II Class A Common Stock
HCII
-1,129,193
Closed -$11.1M
HIII
3682
DELISTED
Hudson Executive Investment Corp. III Class A Common Stock
HIII
-2,939,308
Closed -$29M
IIII
3683
DELISTED
INSU Acquisition Corp. III Class A Common Stock
IIII
-946,933
Closed -$9.43M
SCOAW
3684
CALL
DELISTED
ScION Tech Growth I Warrant
SCOAW
-712,561
Closed -$7.1M
SCOA
3685
DELISTED
ScION Tech Growth I Class A Ordinary Shares
SCOA
-2,762,457
Closed -$27.5M
SHQA
3686
DELISTED
Shelter Acquisition Corporation I Class A Common Stock
SHQA
-973,498
Closed -$9.64M
HIIIW
3687
CALL
DELISTED
Hudson Executive Investment Corp. III Warrant
HIIIW
-178,085
Closed -$1.75M
OPALW
3688
CALL
DELISTED
OPAL Fuels Inc. Warrant
OPALW
-100,000
Closed -$828K
SHQAW
3689
CALL
DELISTED
Shelter Acquisition Corporation I Warrants
SHQAW
-260,597
Closed -$2.61M
ARGUW
3690
CALL
DELISTED
Argus Capital Corp. Warrant
ARGUW
-349,998
Closed -$3.52M
COLIW
3691
CALL
DELISTED
Colicity Inc. Warrant
COLIW
-39,992
Closed -$395K
ARGU
3692
DELISTED
Argus Capital Corp. Class A Common Stock
ARGU
-1,120,689
Closed -$11.3M
FLYA.WS
3693
CALL
DELISTED
SOAR Technology Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
FLYA.WS
-335,686
Closed -$3.46M
COVAW
3694
CALL
DELISTED
COVA Acquisition Corp. Warrants to purchase Class A ordinary shares
COVAW
-340,100
Closed -$3.38M
COVA
3695
DELISTED
COVA Acquisition Corp. Class A Ordinary Share
COVA
-1,236,960
Closed -$12.3M
COLI
3696
DELISTED
Colicity Inc. Class A Common Stock
COLI
-1,580,975
Closed -$15.6M
AGCB
3697
DELISTED
Altimeter Growth Corp 2
AGCB
-1,022,896
Closed -$10.1M
CLVS
3698
DELISTED
Clovis Oncology, Inc.
CLVS
-310,123
Closed -$370K
FLYA
3699
DELISTED
SOAR Technology Acquisition Corp.
FLYA
-1,126,699
Closed -$11.6M
RXRA
3700
DELISTED
RXR Acquisition Corp. Class A Common Stock
RXRA
-1,669,480
Closed -$16.4M

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.